Andrew D. Dickinson - Nov 10, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Financial Officer
Signature
/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Stock symbol
GILD
Transactions as of
Nov 10, 2023
Transactions value $
-$61,040
Form type
4
Date filed
11/13/2023, 06:21 PM
Previous filing
Oct 18, 2023
Next filing
Dec 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +1.91K +1.84% 106K Nov 10, 2023 Direct F1
transaction GILD Common Stock Tax liability -$61K -804 -0.76% $75.92 105K Nov 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1.91K -4.41% 41.5K Nov 10, 2023 Common Stock 1.91K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.